Daily news email for March 17, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
Ceva Takes Commercial License for ProBioGen's AGE1.CR Cell Line for Viral Vaccine Production

UCB and Domainex Collaboration Provides Valuable Information on Cancer Drug Target

Medicyte and PRIMACYT Receive Grant to Develop Human Liver Cells for Cell-based Therapies

Annual Report on Celera (Quest) License

Haselmeier Establishes New Pen Injector Assembly Facility in India

BioSpace
Tranzyme Pharma and Norgine Bowel Drug Fails Trial

Anthera Pharmaceuticals, Inc. Tanks as it Halts Phase III VISTA-16 Heart Drug Trial

Tranzyme Pharma and Norgine Bowel Drug Fails Trial, Shares Crash -2.18(42.75%) @ 1:08PM EDT

Anthera Pharmaceuticals, Inc. Tanks as it Halts Phase III VISTA-16 Heart Drug Trial; Stock Falls -2.99(46.57%) @ 1:09PM EDT

New Approach to Treating Type 1 Diabetes Transforming Gut Cells Into Insulin Factories, Columbia University Study

BioSpace - Breaking News
ABC Laboratories, Inc. CEO, Execs See Pay Cut; Pfizer Inc.'s Chief s Pay Triples First Year on Job

Galderma Laboratories Announces Completion of Phase 3 Trials of Investigational Drug Targeting Facial Erythema of Rosacea

Threshold Pharmaceuticals, Inc.' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma

Health Canada Approves Stellar Pharmaceuticals Inc.'s CAMBIA(R) for the Treatment of Acute Migraine

Amerigen Pharmaceuticals Announces ANDA Filing and BYSTOLIC(R) Patent Challenge

Biotech News - Business Wire
Thermo Fisher Scientific Introduces HyCell CHO Cell-Culture Medium

Federal Circuit Affirms En Banc Over $34.2 Million Judgment For Marine Polymer And Permanent Injunction Against HemCon

PURE Bioscience Reports Second Quarter Results

World Pharmaceutical Industry Survey by iCD Research Now Available at MarketPublishers.com

Global Biosensors Market Review by Industry Experts Recently Published at MarketPublishers.com

Biotech News - PR Newswire
American Oriental Bioengineering Inc. Announces Delay in Filing of its Annual Report on Form 10-K for 2011

First Patient Enrolled Into European Registry for Deep Brain Stimulation in Patients With Refractory Epilepsy

ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States

Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region

Sigma-Aldrich Enhances Asia-Pacific Customer Support With New Distribution and Packaging Capabilities in India

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
Shire Surprisingly Pulls Biologics License Application

Biogen Idec Looks Ahead on MS

Asahi Kasei Expands in Healthcare with $2.2 Billion Zoll Medical Buy

Pfizer Ends $350 Million Insulin Pact

Boston Scientific Connects With Vodafone for Cardiac Monitoring

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Research and Markets: Gonorrhea Global Clinical Trials Review, H1, 2012

Research and Markets: Pediatric Cancer Global Clinical Trials Review, H1, 2012

Kips Bay Medical Reports Fourth Quarter and Full Year 2011 Results, Provides Clinical Update & Announces Patent Grants

Advaxis to Present at the 6th Annual International BIO-Europe Spring 2012 Conference

Research and Markets: Hairy Cell Leukemia Global Clinical Trials Review, H1, 2012

Clinical Trials - PR Newswire
Experts Meet to Drive Improvements in Cancer Treatment in Europe

Expertentreffen zur Förderung von Fortschritten in der Krebsbehandlung in Europa

Des experts se réunissent pour améliorer le traitement du cancer en Europe

Star Scientific Files Annual Financial Report; Rock Creek Pharmaceuticals Prepares for National Launch of Anatabloc at GNC Stores

Partnership and Collaboration Take Promising Therapy, RG2833, From Discovery to First-in-Human Trial in Friedreich's Ataxia (FA)

CNN Top Stories
Opinion: Hillary's cookies, 20 years later

Clooney arrested at protest

Avlon: Clooney's focus should be ours

Odd-behaving 'Kony' director detained

Sources identify suspect in Afghan civilian slayings

Contract Pharma
Keller and Heckman Adds Former FDA Tox Expert

ThromboGenics, Alcon in Ocriplasmin Pact

Sigma-Aldrich Expands Capabilities in India

Avanir Appoints Commercial Officer

Aptuit Appoints COO

FDA Drugs- What's New
Postmarketing Requirements and Commitments: Reports

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: Cambios importantes en la etiqueta de seguridad de los medicamentos para reducir el colesterol conocidos como estatinas

FDA Drug Safety Communication: Interactions between certain HIV or hepatitis C drugs and cholesterol-lowering statin drugs can increase the risk of muscle injury

FDA News - Business Wire
EffRxBINOSTO®FDA

Samenvatting: EffRx meldt: FDA keurt BINOSTO goed, eerste en enige behandeling van botontkalking

Simpirica Spine Receives Approval to Begin U.S. IDE Pivotal Study of Its LimiFlex Spinal Stabilization System

BioCardia and Juventas Announce Phase II Development Program of JVS-100 Delivered With the Helical Infusion System to Treat Heart Failure

A EffRx Anuncia: A FDA aprova BINOSTO®, Primeiro e Único Tratamento de Osteoporose Efervescente em uma Solução Tamponada

FDA Press Releases
FDA proposes lower risk classification, guidance for certain tuberculosis tests

FDA proposes lower risk classification for certain tuberculosis tests

FDA approves first generic Lexapro to treat depression and anxiety disorder

La FDA aprueba nuevos implantes de seno rellenos de gel de silicona

FDA approves new silicone gel-filled breast implant

FDA Vaccines, Blood and Biologics - What's New
Flebogamma DIF 5%

Cord Blood Banking Information for Consumers

Cord Blood Banking – Information for Consumers

Cord Blood Banking ââ¬â Information for Consumers

Influenza Virus Vaccine for the 2011 - 2012 Season

FierceBiotech
Amarin stock jumps on patent progress for blockbuster hopeful; OncoGenex seeks $46.8M in stock sale;

Novartis grabs rights to eye drug in $494M deal

Sanofi beefs up former Genzyme unit with Pluromed buyout

After slashing jobs, Pfizer CEO Ian Read draws $25M

FDA questions benefit of Merck and Ariad's bone cancer drug

FierceBiotech IT
Stanford algorithm uncovers drug side effects

Biomatters taps Ammundsen as CEO

Medidata projects big year, settles lawsuit

Accelrys stays on growth track in Q4

Google VC-backed startup plays 'Moneyball' in Big Pharma partnerships

FierceBiotech Research
RNAi, smuggled in a virus, weakens tumors before final radiation blow

Columbia University team re-creates full human immune system in mice

Protein hampers bladder cancer metastasis

Beefed-up aspirin, charged with gas, conquers colon cancer in lab

RhoGDI2 protein hampers bladder cancer metastasis

FiercePharma
Bayer makes prelim offer for Pfizer's animal health unit

Mylan bows out of Rottapharm bidding

Hamburg says FDA needs more leeway to combat drug fakes

Can European pharma's cash flow cover buyback plans

Setting new course, Pfizer CEO gets 44% pay hike

FiercePharma Manufacturing
Pfizer CEO: More than 50 fakes of our drugs discovered last year

Omega gets German plant as part of OTC deal with GSK

Pfizer's new U.K. cold storage facility has hot new vaccines line

J&J's Weldon to get $143M in retirement

Sanofi cuts continue with closing of manufacturing plant in U.K.

FierceVaccines
World has huge unmet vaccine needs

In the clinic, Inovio's HIV vaccine treats as well as prevents

Hep C vaccine heads into further clinical trials

GeoVax steps closer to HIV prevention

MUC1 cancer vaccine starts in the clinic

Health News - BizJournals.com
UnitedHealth Group wins back $20B military contract from TriWest Healthcare

Texas Attorney General sues U.S. Department of Health and Human Services over funding cut

RiboMed Biotechnologies launching brain cancer test

Wells Fargo gives $320,000 to Bay Area nonprofits to mark 160th birthday

RNs at Sutter's Tracy hospital vote to join California Nurses Union

Health News - CNBC
Why the Financials Can Continue to Lead Us Higher

Court lifts hold on drug distributor suspension

Disaster du Jour: JC Penney

Cytori rises on FDA clearance for fat graft device

Supreme Court to release audio in healthcare cases

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
XTL Inks Agreement with Clalit to Aid Product Development

India's Proposed Budget Offers Some More Incentives, Taxes for Biopharma

Grifols Nabs 51% Stake in Alzheimer Disease Dx, Vaccines Firm Araclon

XTL Inks Framework Agreement with Clalit to Aid Product Development

Grifols Nabs 51% Stake in Alzheimer Disease Dx and Vaccines Firm Araclon

Marketwire - Pharma and Biotech
SOHM, Inc. Entering the Huge USA Generic Pharmaceutical Market

Health Canada Approves CAMBIA(R) for the Treatment of Acute Migraine

Galderma Announces Completion of Phase 3 Trials of Investigational Drug Targeting Facial Erythema of Rosacea

Aptalis Pharma Begins Promotion of RECTIV(TM) to Physicians in the U.S.

FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850

MassBio News
Vertex Founder Joshua Boger to Receive MassBio's Henri Termeer Innovative Leadership Award

MassBio Launches New Blog: MassBioHQ

What has made Massachusetts a better place for biotech Make your nomination by 5 PM on Feb. 24th!

What has made Massachusetts a better place for biotech Make your nomination by Feb. 24th!

MassBio's Peter Abair discusses growth in the cluster with US Building Digest

Medical Pharma - PR Newswire
Kensey Nash Announces Mediated Settlement With St. Jude Medical in Angio-Seal License Disputes and 5 Year Extension and Expansion of Collagen Supply Agreement

InGenesis Earns Portion of $492-Million Multiple Award Federal Contract

MedPAC Data Underscores Need for Targeted Medicare Reforms to Strengthen Program Integrity, Protect Patient Care

Sutter Tracy RNs Vote to Join CA Nurses Association in Hard Fought Victory for Voice in Patient Care

Crystal Bowersox To Perform at the Walk with Walgreens Benefiting the Diabetes Research Institute

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Know before you go

Confronting the Gordian knot

Agbiotech 2.0

Tiptoeing around transgenics

Mission Therapeutics

New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

New York Times- Pharmaceuticals
India Orders Bayer to License Patented Cancer Drug

New Worries About Sleeping Pills

India Overrules Bayer, Allowing Generic Drug

Trial Shows Benefit in Earlier Use of Zytiga

Setback on AIDS Pill Is Re-Evaluated

OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

Outsourcing-Pharma
European CMO market will double in just 6 years, says Frost & Sullivan

Social network sites is key to trial recruitment success, says expert

Social network sites key to trial recruitment success, says expert

An experienced CMO is key to successful biologics development says Cobra Biologics

Parexel discusses transdermal drug delivery techs

Pharma News - Business Wire
VBL Therapeutics Presents Positive Phase 2 Data for VB-201 in Psoriasis and Atherosclerosis at the Late-Breaking Abstract Session of the American Academy of Dermatology 70th Annual Meeting

St. Louis-based Carey, Danis & Lowe Files Federal Suit in Illinois Against the Maker of Zoloft

Results of 503-Patient Clinical Study of AspenBio Pharma's AppyScore Blood Test Show 97% Negative Predictive Value for Absence of Acute Appendicitis in Children and Adolescents Presenting with Abdominal Pain

Cubist Opens Expanded Research and Development Facility

Salix Pharmaceuticals Closes Sale of Convertible Notes

Pharma News - PharmiWeb
Sunpeaks Ventures Addresses Stock Volume and Price Activity

David Nolan to Present at Talent Forward 2012

Hospitals, Healthcare Providers to Benefit from New Premier Agreements for Fetal Monitoring Equipment

Europe Blood Banking Market Potential Discussed in New VPG Report Published at Marketpublishers.Com

HeartWare Receives 54-Patient Allotment From FDA Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial

Pharma News - PR Newswire
Obesity Raises Death Risk Tied To Sleeping Pills

Medical Device Study Delivers Marketing Budget and Staffing Metrics to Promote Efficient Use of Resources

Don't Give Your Pet a Deadly Dose; Medicines Top the List of Household Poisons for Pets

Argus Health Systems to Participate in NCPDP Focus Group

petMD.com Pays Tribute to Irish Dog Breeds on St. Patrick's Day

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

Ascent Scientific licenses novel clathrin inhibitors from Freie Universität Berlin, University of Newcastle and Children's Medical Research Institute

PRWeb - Biotechnology
Bayer CropScience Releases Podcast On Sustainability In Agriculture: A...

Spectrum Announces PerkinElmer Distribution Agreement and Release of...

Global Electrophoresis Equipment and Supplies Market to Reach US$1.7...

Huron Legal Selects PureDiscovery for eDiscovery Semantics

Biomar Invests 2 Million Euros in Its Factory in Order to Produce...

PRWeb - Pharmaceuticals
Consumer Reports Targets FDA Approval Process: Recalled Hip...

HealthyPlace.com Re-launches Award Winning Mental Health Information...

Zoloft During Pregnancy Linked to Increased Heart Defects Risk

Heartbeat Ideas Bill Drummy Appointed to Pharmaceutical Executive...

Survey Finds Women In Their 30s & 40s Overestimate Fertility

Scientific American
Snowflake Growth Successfully Modeled from Physical Laws

'Horizontal Tornado' Captured By Amateur Videographer

Low Doses of Hormonelike Chemicals May Have Big Effects

Snowflake Growth Successfully Modeled for the First Time

Low Doses of Hormone-like Chemicals May Have Big Effects

Sports - ESPN Basketball
Saint Louis rides defense to win over Memphis

Ohio holds on to shock fourth-seeded Michigan

McCollum sparks Lehigh to upset of No. 2 Duke

North Carolina rolls past overmatched Vermont

Norfolk St. shoots lights out, stuns No. 2 Mizzou

Sports News - ESPN
Penn State alum Harris: Trustees must go

Sandusky's lawyer asks for accusers' records

Wisconsin officials shocked by Chadima case

PSU officials get subpoenas in Sandusky case

Poll: Paterno favored for renaming of stadium

Xconomy Life Sciences
In Boston Life Sciences News: Akili, Kala, And Genocea

OncoGenex Snags $50M for Prostate Cancer Drug Plan

Peter Schultz on New Merck-Funded Institute: Were Getting Lots of Resumes

Life Sciences News Roundup: InflammaGen, HemaQuest, ImThera & More

Peter Schultz on New Merck-Funded Institute: Were Getting Lots of Resumes

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)